Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis

BACKGROUND: Currently, there is no topical treatment available for any form of cutaneous leishmaniasis (CL) in most of the endemic areas. The aim of the current study was to develop a topical nano-liposomal Amphotericin B (AmB) for the treatment of CL. METHODOLOGY/PRINCIPAL FINDINGS: Liposomes conta...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Parasitol Drugs Drug Resist
Main Authors: Jaafari, Mahmoud Reza, Hatamipour, Mahdi, Alavizadeh, Seyedeh Hoda, Abbasi, Azam, Saberi, Zahra, Rafati, Sima, Taslimi, Yasaman, Mohammadi, Akram Miramin, Khamesipour, Ali
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2019
Assuntos:
Includes articles from the special issue “Novel therapies for cutaneous leishmaniasis”, pp. 106 - 179
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6904837/
https://ncbi.nlm.nih.gov/pubmed/31582344
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijpddr.2019.09.004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados